Harneet Singh, MD
Internal Medicine · Bangor, MENPI 1295264893
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 41.1% of the total. Reporting peaked in 2023 at $745 and has fallen 97.0% since, to $23 in 2025. Among internal medicine clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $103.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$553
- AstraZeneca$192
- Johnson & Johnson$148
- Novo Nordisk$125
- SK Life Science, Inc.$100
- Lilly USA, LLC$94
- plus $133 from 3 others
What the payments were for
- Travel & lodging$55341%
- Food & beverage$79259%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 1 | $553 |
| AstraZeneca | 2 | $192 |
| Johnson & Johnson | 2 | $148 |
| Novo Nordisk | 1 | $125 |
| SK Life Science, Inc. | 2 | $100 |
| Lilly USA, LLC | 2 | $94 |
| Boehringer Ingelheim | 1 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,345 in reported general payments places this provider in the 90th percentile of 445 internal medicine providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $9,849 |
| ClopidogrelClopidogrel Bisulfate | 26 | $330 |
| Metoprolol Succinate | 29 | $330 |
| Atorvastatin Calcium | 24 | $191 |
| Pantoprazole Sodium | 19 | $121 |
| Furosemide | 22 | $92 |
| Prednisone | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bangor
- Muhammad Umer AhmedBangor$2K
- Harleen DehalBangor$2K
- Samer Al-AmeriBangor$1K
- David KoffmanBangor$1K
- Ali Al OmariBangor$959
- Syed Asfand Yar ShahBangor$847
- Manpreet AroraBangor$781
- Kymberly HunterBangor$591
- David BarryBangor$393
- Rhashelia Crawford FlorisBangor$391
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.